Latest news
Dr Cohen on Future Research Avenues for Cevostamab in R/R Myeloma - OncLiveOncLive · Fri, 07 Aug 2026 19:12:33 GMTFixed-Duration Cevostamab Yields Durable Responses Off Therapy - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 20:08:49 GMTDr Cohen on Phase 1 Efficacy Data for Cevostamab in R/R Myeloma - OncLiveOncLive · Tue, 04 Aug 2026 19:15:33 GMTHow Effective is Fixed-Duration Cevostamab in Multiple Myeloma? - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 12:08:44 GMTCalifornia Traffic Ticket Attorney Adam Cohen Launches New Website to Help Drivers Contest Citations Without Going to Court - USA TodayUSA Today · Tue, 04 Aug 2026 08:05:00 GMTDr Cohen on FcRH5 as a Therapeutic Target in Multiple Myeloma - OncLiveOncLive · Tue, 04 Aug 2026 03:17:03 GMTAs He Becomes Supreme Master, Brother Adam Cohen (Georgia, 2006) Wants to Pass The Luck Forward - aepi.orgaepi.org · Fri, 31 Jul 2026 13:31:38 GMTCevostamab Shows Durable Responses in Relapsed/Refractory Multiple Myeloma - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 16:02:21 GMT